Iovance Biotherapeutics (IOVA): TIL Cancer Breakthrough or Biotech Bust?
Company Overview: Pioneering TIL Therapy in Oncology Iovance Biotherapeutics is focused on developing tumor-infiltrating lymphocyte (TIL) therapies – a novel form of immunotherapy where a patient’s own T cells, harvested from their